BATTAGLIA, GLORIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.093
AS - Asia 2.741
EU - Europa 1.139
SA - Sud America 439
AF - Africa 141
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.558
Nazione #
US - Stati Uniti d'America 3.013
SG - Singapore 1.033
CN - Cina 815
BR - Brasile 358
SE - Svezia 335
IE - Irlanda 324
VN - Vietnam 323
HK - Hong Kong 192
TR - Turchia 165
FR - Francia 97
ZA - Sudafrica 83
NL - Olanda 77
DE - Germania 58
CA - Canada 45
FI - Finlandia 43
RU - Federazione Russa 40
IN - India 36
GB - Regno Unito 35
AR - Argentina 30
CI - Costa d'Avorio 30
IT - Italia 30
BD - Bangladesh 28
UA - Ucraina 23
MX - Messico 21
AT - Austria 20
IQ - Iraq 16
JP - Giappone 15
TH - Thailandia 14
ES - Italia 11
CO - Colombia 10
EC - Ecuador 10
PL - Polonia 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
JO - Giordania 9
MA - Marocco 9
PH - Filippine 9
PK - Pakistan 9
VE - Venezuela 9
CL - Cile 8
KR - Corea 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
ID - Indonesia 6
BO - Bolivia 5
PA - Panama 5
BG - Bulgaria 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
LY - Libia 4
OM - Oman 4
PE - Perù 4
PS - Palestinian Territory 4
AU - Australia 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
BY - Bielorussia 2
EG - Egitto 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
NP - Nepal 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CH - Svizzera 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
PT - Portogallo 1
RS - Serbia 1
Totale 7.556
Città #
Chandler 524
Singapore 491
Ashburn 374
Dublin 324
Santa Clara 301
San Jose 264
Hong Kong 180
Beijing 160
Dallas 137
Dearborn 130
Izmir 127
Nanjing 111
Ho Chi Minh City 105
Boardman 93
Johannesburg 79
Hanoi 78
New York 71
Princeton 70
Los Angeles 65
Lauterbourg 57
Shanghai 50
Columbus 41
Wilmington 41
Moscow 35
Helsinki 34
Hebei 30
Nanchang 29
São Paulo 29
Abidjan 27
Shenyang 27
Kocaeli 26
Buffalo 24
Toronto 23
Munich 21
Changsha 20
The Dalles 20
Guangzhou 19
Hangzhou 19
Kunming 19
Tianjin 18
Vienna 18
Jiaxing 17
Seattle 17
Frankfurt am Main 16
Haiphong 16
Hefei 14
Jinan 13
Belo Horizonte 12
Jacksonville 12
Montreal 12
Rio de Janeiro 12
San Mateo 12
Tokyo 12
Zhengzhou 12
Da Nang 10
Fremont 10
London 10
Norwalk 10
Brussels 9
Council Bluffs 9
Orem 9
Turku 9
Atlanta 8
Chicago 8
Milan 8
Porto Alegre 8
San Francisco 8
Stockholm 8
Amman 7
Baghdad 7
Campinas 7
Houston 7
Hải Dương 7
Warsaw 7
Ann Arbor 6
Bangkok 6
Boston 6
Brooklyn 6
Chennai 6
Curitiba 6
Denver 6
Poplar 6
Tashkent 6
Brasília 5
Dhaka 5
Nuremberg 5
Panama City 5
Rome 5
Salvador 5
Wuhan 5
Borås 4
Bình Phước 4
Cambridge 4
Can Tho 4
Caxias do Sul 4
Dubai 4
Guayaquil 4
Lanzhou 4
Leawood 4
Muscat 4
Totale 4.783
Nome #
Long-term treatment for gastric and duodenal ulcer 163
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 159
H2-blockers in the treatment of ulcer disease in the elderly 155
Individualized treatment of duodenal ulcer disease. A pilot study 152
Clinical markers of slow healing and relapsing gastric ulcer 152
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 152
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 151
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 147
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 147
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 146
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 146
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 143
Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study 143
Gastric and duodenal ulcer in the same patient 142
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 136
CARATTERISTICHE EPIDEMIOLOGICHE, CLINICHE E FUNZIONALI IN PAZIENTI CON SANGUINAMENTO DA ULCERA DUODENALE 134
Azithromycin for the cure of Helicobacter pylori infection 134
Compliance with therapy for ulcer disease: clinical experience and review of the literature 132
Cefixime for the eradication of helicobacter pylori 131
TERAPIA DI MANTENIMENTO PER UN ANNO CON ANTI-H2 NELL'ULCERA PEPTICA DELL'ANZIANO: IMPORTANZA DELLA SINTOMATOLOGIA COME MARKER DI RECIDIVA 130
A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study 127
Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin 127
Mucosal pepsin and group I pepsinogen concentration in peptic ulcer patients with a history of bleeding 124
A preliminary report on Helicobacter pylori and antral gastrin concentration in patients with duodenal ulcer 122
MODIFICAZIONI DELLA MUCOSA GASTRICA IN CORSO DI TRATTAMENTO DELLA MALATTIA ULCEROSA 120
Double, 14-day therapy with omeprazole and clarithromycin is not sufficiently effective for the cure of Helicobacter pylori infection. Comparison with two triple 7-day therapies 118
Milk consumption and duodenal ulcer outcome: A short- and long-term study 117
A therapeutic strategy after a first ineffective cure of H. pylori infection. One-centre experience on 74 consecutive patients 117
Clarithromycin for the cure of Helicobacter pylori infection: One or two weeks of treatment 117
LA BULBODUODENITE NON ULCEROSA: ASPETTI CLINICI E TRATTAMENTO FARMACOLOGICO 115
H2antagonists and gastric ulcer: A multicenter, randomized, double-blind, controlled study comparing nizatidine with ranitidine 114
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 114
Disappearance of gallbladder wall lesions after treatment with ursodeozycolic acid 114
Blood pepsinogen as a subclinical marker for duodenal ulcer 113
Fasting and post-prandial serum gastrin concentrations in peptic ulcer disease. Pathophysiological considerations in relationship to the different localization 113
Gastric ulcer and stomach aging: Pathophysiology and clinical implications 112
ACIDO N-ACETILNEURAMINICO DOPO PENTAGASTRINA E SECRETINA IN SOGGETTI CON ULCERA DUODENALE E DISPEPSIA NON ULCEROSA 112
Does Helicobacter pylori infection eradication modify peptic ulcer prevalence? 107
Gastric bicarbonate secretion in high-relapsing, smoking duodenal ulcer patients 105
The appearance of gord in patients with duodenal ulcer after eradication of Helicobacter pylori (Hp) infection: A 4 year prospective study 104
Studio scintigrafico del tempo di svuotamento gastrico in pazienti con ulcera duodenale 101
Ulcera gastrica, ulcera duodenale e gruppi sanguigni "maggiori e minori". Aspetti epidemiologici, correlazioni funzionali, implicazioni cliniche 96
Helicobacter pylori infection, cigarette smoking and alcohol consumption. A histological and clinical study on 286 subjects 96
The natural history of duodenal ulcer disease 95
EFFETTO DELLA NIZATIDINA E DEL MISOPROSTOL SULL'ATTIVITA PEPTICA E SUL MUCO GASTRICO SOLUTO 92
Personality traits and gastric acid secretion in ulcer disease 91
ULCERA PEPTICA E CIRROSI EPATICA. CONSIDERAZIONI CLINICO-EPIDEMIOLOGISCHE 90
Risk factors of duodenal ulcer bleeding: the role of smoking and nicotine 89
Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study 87
Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series 86
Sucralfate gel versus ranitidine in the treatment of gastroesophageal reflux disease: A controlled study 85
Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: One or two weeks? 85
Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication 84
Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori 83
Helicobacter pylori (Hp) eradication in functional dyspepsia: A prospective randomized 3 year study 81
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs 81
Sucralfate for preventing gastric ulcer relapse: A controlled prospective study 81
Sucralfate and cisapride in the treatment of duodenogastric reflux and dyspepsia: A randomized study 80
Helicobacter pylori eradication: Can a successful therapy be predicted? 80
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 79
Lymphoid follicles in gastric mucosa of Helicobacter pylori infected patients regress after eradication treatment 78
Valutazione clinica della gastrinemia basale nella malattia ulcerosa 76
Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study 75
Optimal PPI-based triple therapy for the cure of Helicobacter pylori infection: a single center comparison of four 14-day schedules 73
Early fall of anti Helicobacter pylori IgG in eradicated patients with non-ulcer dyspepsia 73
High IgE serum levels and "peptic" ulcers: clinical and functional approach 71
One year follow-up of malt lymphoma of the stomach: Evidence for the need of an accurate diagnostic management 66
Helicobacter pylori and Serum Pepsinogen A, Pepsinogen C, and Gastrin: A Methodological Note 64
Seasonal Fluctuations in Peptic Ulcer Bleeding: An Italian Experience 58
LA TERAPIA DELLA MALATTIA ULCEROSA NELL'ANZIANO: STUDIO PROSPETTICO RANDOMIZZATO CON FARMACI ANTISECRETORI 51
Totale 7.634
Categoria #
all - tutte 25.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 29 10 7
2021/2022269 0 0 1 17 14 2 3 25 18 15 28 146
2022/20231.461 133 149 131 132 95 184 7 122 415 6 71 16
2023/2024402 13 49 11 9 31 127 7 34 17 34 33 37
2024/20251.742 36 78 90 100 284 284 92 71 200 115 112 280
2025/20262.772 303 250 333 222 456 216 287 88 389 228 0 0
Totale 7.634